Imara Stock News

Raymond James reduced the price target on Intercontinental Exchange, Inc. (NYSE: ICE) from $161 to $157. Intercontinental Exchange shares rose 0.2% to $130.79 in pre-market trading. Loop Capital cut

Interim results in Ardent trial for sickle cell disease showed no significant difference in median annualized rate of vaso-occlusive crises in high-dose group versus placebo in an intent-to-treat popu

Imara Inc (NASDAQ: IMRA) shares are falling after interim analyses of its Ardent Phase 2b trial of tovinontrine (IMR-687) in sickle cell disease (SCD) and Forte Phase 2b trial in beta-thalassemia.�

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Discontinues Phase 2 Study Of Imsidolimab In Acne Anaptys Bio, Inc. (NASDAQ: ANAB) said the Ph

Imara (NASDAQ: IMRA ) reported its Q4 earnings results on Tuesday, March 15, 2022 at 07:00 AM. Here''s what investors need to know about the announcement. Earnings Imara beat estimated earnings by 29.33%, reporting an EPS … Full story available on Benzinga.com

Imara (IMRA) CEO, Rahul Ballal on Q4 2021 Results - Earnings Call Transcript

Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ: IDYA ) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi Trends (NASDAQ: CTRN ) is projected to report quarterly earnings at $1.12 per share on revenue of $250.54 million. • Precision BioSciences (NASDAQ: DTIL ) is likely to report quarterly loss at $0.47 per share on revenue of $7.75 million. • SPX FLOW (NYSE: FLOW ) is estimated to report quarterly loss at $0.17 per share on revenue of $10.88 million. • Brickell Biotech (NASDAQ: BBI ) is likely to report quarterly loss at $0.08 per share on revenue of $150.00 thousand. • Imara (NASDAQ: IMRA ) is expected to report earnings for its fourth quarter. • Gamida Cell (NASDAQ: GMDA ) is estimated to report earnings for its fourth quarter. • Syros Pharmaceuticals (NASDAQ: SYRS ) is likely to report quarterly loss at $0.47 per share on revenue of $4.80 million. • Global X Guru Index ETF (NYSE: GURU ) is likely to report quarterly loss at $0.

These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways. The post 7 Biotech Stocks With Key Catalysts in March appeared first on Invest

BOSTON, March 08, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suff

BOSTON, March 08, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffer

Gainers Digital World Acquisition Corp . (NASDAQ: DWAC ) rose 28.5% to $108.31 in pre-market trading. Just hours after launching on Sunday night in Apples App Store, Donald Trump''s new social media app Truth Social encountered a partial outage. Truth Social is an app created by Trump''s new company, Trump Media & Technology Group, which announced a SPAC merger with Digital World Acquisition in October. BRC Inc. (NYSE: BRCC ) rose 25.1% to $23.50 in pre-market trading after gaining around 4% on Friday. Phunware, Inc (NASDAQ: PHUN ) rose 18.8% to $3.78 in pre-market trading. Phunware, recently announced the launch of its PhunToken (PHTK) liquidity pool rewards program. Ocugen, Inc. (NASDAQ: OCGN ) rose 17.1% to $4.05 in pre-market trading. The FDA has lifted its clinical hold on Ocugens investigational new drug application seeking approval to conduct testing of the COVID-19 vaccine Covaxin in the U.S. Healthcare Capital Corp. (NASDAQ: HCCC ) shares rose 13.4% to $11.44 in pre-market trading.

Insiders are scooping up these penny stocks in February. The post Best Penny Stocks To Buy? 3 To Watch With Insider Buying In February appeared first on Penny Stocks to Buy, Picks, News and Informatio

Insiders are scooping up these penny stocks in February. The post Best Penny Stocks To Buy?

U.S. existing home sales surged 6.7% to an annual rate of 6.5 million in January. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates thei

Although Eurozone economy grew 0.3% on quarter during the last three months of 2021, in-line with flash estimates, there were a few notable insider trades. When insiders purchase or sell shares, it in